Navigation Links
Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
Date:3/12/2009

HAE:TSX

MONTREAL, March 12 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE) released today the results of its first quarter ended January 31, 2009.

Results

Revenues amounted to $19,226, as compared to $24,674 for the same quarter last year. Revenues were exclusively derived from the sale of legacy fibrin sealant application devices. Operating expenses amounted to $2.7 million, up from $1.2 million for the same quarter last year. The increase was mainly related to the purchase of supplies and materials associated with the validation of the Company's manufacturing facility, and the pivotal phase II/III clinical trials of its lead product candidate (which had been planned to start by mid-2009), as well as the hiring of personnel and legal and consulting fees. The consolidated net loss for the quarter amounted to $2.6 million, or $0.01 per share, as compared to $1.2 million, or $0.01 per share, for the same quarter last year.

Financial Position

Cash, cash equivalents and temporary investments amounted to $1.4 million as of January 31, 2009, as compared to $4.6 million as at October 31, 2008.

On February 13, 2009, Haemacure, having failed to obtain adequate financing to maintain the level of its operations, implemented major cost cutting measures intended to provide the Company with a window of approximately 90 days in which to either arrange a bridge loan, obtain new financing, or sell or merge the Company. The Company has since retained PricewaterhouseCoopers Corporate Finance, Inc. to assist with the sale or merger of the Company.

"We have taken the necessary steps to lengthen our runway in these unprecedented financial and economic times. While these measures are difficult for all involved we have had tremendous support from our directors, employees, suppliers and business partners. I am encouraged by the number of industry members that have come forw
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Haemacure Restructures - Seeks Financing or Sale of the Company
2. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
3. Haemacure Announces Fiscal 2008 Results
4. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
5. Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
6. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
7. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
8. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
9. Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
10. Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
11. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... study has found that India,s shocking rates of suicide ... who are clinging to tiny smallholdings less than ... such as cotton and coffee, that are highly susceptible ... range of previous case studies that point to a ... the ,liberalisation, of the nation,s economy during the 90s. ...
(Date:4/17/2014)... patients adrenaline after they suffer a cardiac arrest outside ... surviving long-term, according to new research conducted at St. ... have a cardiac arrest get adrenaline, which has been ... said Dr. Steve Lin, an emergency physician and trauma ... medical treatment, long-term survival rates of patients who suffer ...
(Date:4/17/2014)... as the leading weapon against the deadly disease could ... research indicating it simply needs to be administered differently. ... cheap anti-malarial drug chloroquine in treating and preventing the ... half a million people each year around the world. ... to chloroquine, but research carried out at the Australian ...
(Date:4/16/2014)... Consider the marvel of the embryo. It begins as ... as they multiply to become the cells of our lungs, ... body. , Now, in a feat of reverse tissue engineering, ... coding that allows embryonic cells to proliferate and transform into ...
(Date:4/16/2014)... Therapeutics, Inc. (NASDAQ: CLDX) announced today that final data ... tumors, including long-term patient follow-up, have been published in ... The data demonstrate robust antibody and T cell responses ... advanced cancers and suggest that CDX-1401 may predispose patients ...
Breaking Medicine News(10 mins):Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Scientists find new way to fight malaria drug resistance 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4
... French and Spanish . , Researchers at ... ,gene E, which leads to the death of tumour cells derived from ... this new gene is that its use to fight cancer can reduce ... effective treatment for cancer. This research was conducted by Ana ...
... ... Surgeons (ASPS), are available to discuss the recently proposed cosmetic surgery tax. , ... Arlington Heights, IL (Vocus) ... Surgeons (ASPS), are available to discuss the recently proposed cosmetic surgery tax., , ,WHAT: ...
... ... IVD manufacturers, distributors and industry service providers about the state of their company, international ... ... medical device regulatory consulting firm Emergo Group Inc. recently surveyed medical device and ...
... ... in a national movement to raise awareness for a disease that affects 24 million Americans. ... Richmond, VA (Vocus) November ... recognizes National Diabetes Awareness Month, observed annually during the month of November. Nearly 24 ...
... ... report on how to generate free leads through your website. , ... (PRWEB) November 24, 2009 -- 2009 has been another ... the strain to keep their businesses afloat and reduce costs. Typically the first items on ...
... , RESTON, Va., Nov. 24 Lincoln County ... Maine with two small hospitals and retirement communities, employing more than 1,200 ... you,re not getting successful backup, you,re not doing your job," says Brooks ... case with many hospitals in Maine, budgets are extremely tight for LCH, ...
Cached Medicine News:Health News:Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage 2Health News:Leading Plastic Surgery Experts Available to Discuss Proposed ,Cosmetic Surgery Tax 2Health News:Medical Device Industry Positive About 2010 – Survey 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 3Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:Replay 4 Customer Takes Risk, Fights for Budget to Protect Information Systems 2
(Date:1/14/2014)... Jan. 14, 2014  Luminex Corporation (Nasdaq: LMNX ) ... fourth quarter of 2013 on Monday, February 3, 2014. A ... the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ... discuss the operating highlights and financial results for the fourth ...
(Date:1/14/2014)... Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s ... a targeting guide with accompanying instrumentation to place and ... adjunct to the soft tissue (e.g. ligament) repair or ... tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... The Advanced Wound Management Division of Smith & Nephew, ... SN; NYSE: SNN ), highlighted the results of ... Wound Therapy (NPWT) achieves many of the common treatment ... a reduction in wound dimension, exudate, and improvement in ...
... Medical Holdings Corporation ("Select") (NYSE: SEM ), the ... had received notice of the exercise of the underwriters, ... Select,s common stock at a price per share of ... 2009, subject to customary closing conditions. The over-allotment option ...
Cached Medicine Technology:Gauze-based NPWT Capable of Achieving Same Treatment Goals as Foam-based NPWT 2Gauze-based NPWT Capable of Achieving Same Treatment Goals as Foam-based NPWT 3Gauze-based NPWT Capable of Achieving Same Treatment Goals as Foam-based NPWT 4Select Medical Holdings Corporation Announces Exercise of Underwriters' Option to Purchase Additional Shares 2
HST, multi frequency Side Fire "T intraoperative transducer. A wide field of view is this transducers benefit....
This convex sector mechanical sector transducer provides real-time photo-realistic images....
Wide band, Super High Density endovaginal transducer provides a 180 field of view allowing imaging of the entire uterus and cervix with minimal transducer movement....
Provides tremendous image quality along with a 180 degree field of view....
Medicine Products: